|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
09-15-2010, 08:26 PM
|
|||
|
|||
Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer
Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. Â The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Synta expands STA-9090 Phase 2 clinical trial in NSCLC | cancerfr | AIDS-related cancer | 0 | 10-05-2010 03:07 AM |
| Commencement Of A Phase II Clinical Trial Of SG2000 In Ovarian Cancer | cancerfr | Ovarian Cancer | 0 | 09-17-2010 01:48 AM |
| Threshold Pharmaceuticals initiates Phase 2 clinical trial of TH-302 in patients with | cancerfr | Pancreatic Cancer | 0 | 07-01-2010 07:45 PM |
| FDA approves continuation of Phase IIb clinical trial for superficial bladder cancer | cancerfr | Pancreatic Cancer | 0 | 05-03-2010 06:10 PM |
| OSI Pharmaceuticals completes enrollment in Phase III clinical trial of Tarceva | cancerfr | Oral Cancer | 0 | 04-26-2010 02:19 PM |
Linear Mode
